WallStSmart
AORT

Artivion Inc

NYSE: AORT · HEALTHCARE · MEDICAL DEVICES

$34.64
-4.65% today

Updated 2026-04-29

Market cap
$1.68B
P/E ratio
164.95
P/S ratio
3.81x
EPS (TTM)
$0.21
Dividend yield
52W range
$23 – $48
Volume
0.4M

Artivion Inc (AORT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+191.6%
Last 4 quarters
Revenue YoY growth
+19.2%
Most recent quarter
EPS YoY growth
+143.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.9%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+26.9%
2025-08-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-12$0.17+191.6%$40.10$36.60-8.7%
2025-11-06$0.16+433.3%$46.51$44.87-3.5%
2025-08-07$0.03+1009.1%$32.27$40.95+26.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.06$0.17+191.6%$115.99M+19.2%
2025-09-30$0.03$0.16+433.3%$113.39M+18.4%
2025-06-30$-0.00$0.03+1009.1%$112.97M+15.3%
2025-03-31$0.05$-0.01-126.7%$98.98M+1.6%
2024-12-31$0.04$-0.39-1149.6%$97.31M+3.9%
2024-09-30$-0.06$-0.05+16.7%$95.78M+9.0%
2024-06-30$-0.02$-0.05-150.0%$98.02M+9.8%
2024-03-31$-0.09$0.06+166.7%$97.43M
2023-12-31$-0.10$-0.10+0.0%$93.67M
2023-09-30$-0.06$-0.24-300.0%$87.85M
2023-06-30$-0.08$-0.07+12.5%$89.25M

Frequently asked questions

Has Artivion Inc beaten earnings estimates?
Artivion Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +191.6% over the last 1 quarters.
How does AORT stock react to earnings?
AORT stock has moved an average of +4.9% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Artivion Inc's revenue growth rate?
Artivion Inc reported year-over-year revenue growth of +19.2% in its most recent quarter, with EPS growing +143.2% year-over-year.